Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

Gastroenterology - 1 Feb 2008

Hézode Christophe, Zafrani Elie Serge, Roudot-Thoraval Françoise, Costentin Charlotte, Hessami Ali, Bouvier-Alias Magali, Medkour Fatiha, Pawlostky Jean-Michel, Lotersztajn Sophie, Mallat Ariane

Abstract excerpt

BACKGROUND & AIMS: Steatosis is highly prevalent in patients with chronic hepatitis C (CHC) and has been reported to increase fibrosis and reduce the rate of viral eradication. Two recent studies indicate that endocannabinoids promote experimental steatosis via activation of hepatic CB1 receptors. We therefore investigated the impact of cannabis smoking on steatosis severity during CHC. METHODS: A total of 315...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Fatty Liver

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Logistic Models

Share to Multivariate Analysis

Share to Predictive Value of Tests

Share to Severity of Illness Index

Share to Viral Load

Source

Identifiers

PMID: 18242211
DOI: 10.1053/j.gastro.2007.11.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.PMID 18242211Read ↗

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.Semantic proximity Read ↗

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.Semantic proximity Read ↗

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.Semantic proximity Read ↗

Hepatitis C and steatosis.Semantic proximity Read ↗

Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.Semantic proximity Read ↗

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: why does it really matter?Semantic proximity Read ↗

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.Semantic proximity Read ↗

Hepatic steatosis in Iranian patients with chronic hepatitis C.Semantic proximity Read ↗

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.Semantic proximity Read ↗

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Semantic proximity Read ↗

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.